Drug Profile
Celecoxib topical - Promius Pharma
Alternative Names: DFD-07Latest Information Update: 11 Nov 2021
Price :
$50
*
At a glance
- Originator Promius Pharma
- Class Antimigraines; Antineoplastics; Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrazoles; Small molecules; Sulfonamides
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II/III Actinic keratosis
Most Recent Events
- 27 Oct 2020 Clinical development for Actinic keratosis (In adults) is still ongoing in USA (NCT03116698)
- 27 Oct 2020 No development reported - Phase-II for Actinic keratosis (In the elderly, In adults) in Germany (Topical)
- 05 Jul 2018 Dr. Reddy's Laboratories Limited completes a phase II/III trial in Actinic keratosis (In adults) in USA (Topical) (NCT03116698)